Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001031626 | SCV001194932 | pathogenic | Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative | 2021-12-02 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 3-5 of the CYBA gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein. A similar copy number variant has been observed in individual(s) with chronic granulomatous disease (PMID: 18422995). This variant disrupts a region of the CYBA protein in which other variant(s) (p.Arg90Trp) have been determined to be pathogenic (PMID: 10910929, 20167518; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |